Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements.
about
Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Decitabine demonstrates antile ...... kemia with MLL rearrangements.
@en
Decitabine demonstrates antile ...... kemia with MLL rearrangements.
@nl
type
label
Decitabine demonstrates antile ...... kemia with MLL rearrangements.
@en
Decitabine demonstrates antile ...... kemia with MLL rearrangements.
@nl
prefLabel
Decitabine demonstrates antile ...... kemia with MLL rearrangements.
@en
Decitabine demonstrates antile ...... kemia with MLL rearrangements.
@nl
P2093
P2860
P1476
Decitabine demonstrates antile ...... kemia with MLL rearrangements.
@en
P2093
B J Krause
C Junghanss
C Konkolefski
H Murua Escobar
P2860
P2888
P356
10.1186/S13045-018-0607-3
P577
2018-05-04T00:00:00Z
P6179
1103815334